BIIB241220C145000
- 16.50
- 0.000.00%
Biogen Newsroom
PTC Therapeutics Submits NDA for Friedreich Ataxia Treatment Vatiquinone
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Eli Lilly Alzheimer's Therapy Approved in China
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Why Are Biogen, Pfizer, and GSK Trading at a Discount?
Worst Performing Stocks for Tax Loss Selling – Wolfe
Another Week, Another Index Record | Lkive Stock
Netflix, Ford, Biogen: Trending Tickers
Stifel Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $175
Biogen Downgraded to Hold From Buy at Stifel
Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $175 From $275
Palantir, Tesla, and Other Stocks That Have Soared Past Wall Street's Price Targets
Weekly Buzz: Tech stocks hit high scores on ominous day
Palantir, MicroStrategy Could Be Added to Nasdaq 100. Moderna, Super Micro Could Be Dropped
Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.
Market Mixed on Friday the 13th | Livestock
Biogen Stock Touches 52-week Low at $153.55 Amid Challenges